Is endometriosis a benign disease? Modern controversial aspects of endometriosis-associated ovarian tumors

Condition tags

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (60)

• A dose‐ranging study to determine the efficacy and safety of 1, 2, and 4 mg of dienogest daily for endometriosis via openalex
• Big Picture of Endometriosis Helps Provide Guidance on Approach to Teens via openalex
• Cancer risk after hospital discharge diagnosis of benign ovarian cysts and endometriosis via openalex
• Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary via openalex
• Consensus on current management of endometriosis via openalex
• Current Strategies for Endometriosis Management via openalex
• Dienogest via openalex
• Dienogest: an oral progestogen for the treatment of endometriosis via openalex
• Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells via openalex
• Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis via openalex
• Dienogest increases the progesterone receptor isoform B/A ratio in patients with ovarian endometriosis via openalex
• Effectiveness of the cyclic administration of dienogest in a case of pathological disappearance of intestinal endometriosis via openalex
• Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model via openalex
• Endometriosis via openalex
• Endometriosis: a life cycle approach? via openalex
• Endometriosis-associated Malignancy via openalex
• Endometriosis in premenarcheal girls who do not have an associated obstructive anomaly via openalex
• EPIDEMIOLOGY OF ENDOMETRIOSIS via openalex
• Evidence of a genetic link between endometriosis and ovarian cancer via openalex
• Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis via openalex
• In vitro fertilization, endometriosis, nulliparity and ovarian cancer risk via openalex
• Malignant Transformation from Endometriosis to Atypical Endometriosis and Finally to Endometrioid Adenocarcinoma within 10 Years via openalex
• New insights in the pathophysiology of ovarian cancer and implications for screening and prevention via openalex
• On-label and off-label drug use in the treatment of endometriosis via openalex
• Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis via openalex
• Ovarian cancer risk associated with varying causes of infertility via openalex
• Postmenopausal cancer risk after self‐reported endometriosis diagnosis in the Iowa Women's Health Study via openalex
• Postoperative Medical Therapy After Surgical Treatment of Endometriosis: From Adjuvant Therapy to Tertiary Prevention via openalex
• Prognostic implication of endometriosis in clear cell carcinoma of the ovary via openalex
• Recurrence of endometriosis after hysterectomy. via openalex
• Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
• Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis via openalex
• Risk of developing major depression and anxiety disorders among women with endometriosis: A longitudinal follow-up study via openalex
• Role of angiogenesis in endometriosis via openalex
• The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life via openalex
• Theories on the Pathogenesis of Endometriosis via openalex
• The relation between endometriosis and ovarian cancer – a review via openalex
• The risk of cancer and the role of parity among women with endometriosis via openalex
• Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone via openalex
• W2163064788 via openalex
• W2226711154 via openalex
• W2230403972 via openalex
• W1718276241 via openalex
• W4233104412 via openalex
• W1647658753 via openalex
• W1523215342 via openalex
• W6690080468 via openalex
• W2090702820 via openalex
• W2030404955 via openalex
• W2109870736 via openalex
• W2114410175 via openalex
• W2000311445 via openalex
• W2139087961 via openalex
• W2139888809 via openalex
• W1974756790 via openalex
• W1964254460 via openalex
• W2155216639 via openalex
• W2158187504 via openalex
• W2159575833 via openalex
• W1804864865 via openalex

Cited by (4)

• Ultrasound image of ovarian endometrioma as an indicator of external genital endometriosis 2024
• Risk factors for recurrence of ovarian endometriomas after surgical treatment: retrospective cohort study 2021
• Incidence rate and structure of external genital endometriosis in hospital patients 2021
• The value of the assesment of ARID1A expression, prostaglandin E2 synthase and the prostaglandin E2 receptor in patientswith genital endometriosis 2019

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00